Celltrion Prepares Aflibercept For Phase III

Follows In Footsteps Of Denosumab, Omalizumab And Ustekinumab Biosimilars

 
• By David Wallace
  
Clinical_Trial_Puzzle
The Eylea rival is the latest Phase III trial to fall into place for Celltrion • Source: Shutterstock

More from Biosimilars

More from Products